Novozymes A/S (NVZMF)
Company Description
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America.
The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion.
It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions.
In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management.
Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions.
The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

Country | DK |
IPO Date | Oct 15, 2010 |
Industry | Chemicals - Specialty |
Sector | Basic Materials |
Employees | 10,582 |
CEO | Ester Baiget |
Contact Details
Address: Krogshoejvej 36 Bagsvaerd, DK | |
Website | https://www.novozymes.com |
Stock Details
Ticker Symbol | NVZMF |
Exchange | PNK |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001131345 |
CUSIP Number | n/a |
ISIN Number | DK0060336014 |
Employer ID | 00-0000000 |
SIC Code |
Key Executives
Name | Position |
---|---|
Ester Baiget | President & Chief Executive Officer |
Anders Lund | Chief Operating Officer |
Rainer Lehmann | Executive Vice President & Chief Financial Officer |
Amy Byrick | Executive Vice President of Human Health Biosolutions |
Claus Crone Fuglsang | Chief Scientific Officer |
Henrik Joerck Nielsen | Executive Vice President of Strategy & Integration |
Morten Enggaard Rasmussen | Executive Vice President of People & Stakeholder Relations |
Tina Sejersgaard Fano | Executive Vice President of Planetary Health Biosolutions |
Tobias Cornelius Bjorklund | Head of Investor Relations |
Tue Micheelsen | Vice President of Global Sales & Marketing |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 01, 2024 | F-6 POS | Filing |
Mar 27, 2024 | F-6 POS | Filing |
Mar 19, 2024 | F-6 POS | Filing |
Nov 22, 2019 | F-6EF | Filing |
Sep 29, 2017 | F-6 POS | Filing |
Jun 02, 2010 | F-6EF | Filing |
Mar 16, 2010 | F-6EF | Filing |
Feb 24, 2009 | ARS | Filing |
Feb 25, 2008 | ARS | Filing |
Feb 13, 2008 | SUPPL | Filing |